Xeris Biopharma Holdings Inc
NASDAQ:XERS
During the last 3 months Xeris Biopharma Holdings Inc insiders have not bought any shares, and sold 217.2k USD worth of shares. The stock price has increased by 25% over this period (open performance analysis).
The last transaction was made on
Mar 20, 2025
by
Hecht Beth
(Senior Vice President, General Counsel & Secretary)
, who
sold
217.2k USD
worth of XERS shares.
During the last 3 months Xeris Biopharma Holdings Inc insiders have not bought any shares, and sold 217.2k USD worth of shares. The stock price has increased by 25% over this period (open performance analysis).
The last transaction was made on
Mar 20, 2025
by
Hecht Beth
(Senior Vice President, General Counsel & Secretary)
, who
sold
217.2k USD
worth of XERS shares.
Xeris Biopharma Holdings Inc
Glance View
Xeris Biopharma Holdings, Inc. is a holding company. The company is headquartered in Chicago, Illinois and currently employs 294 full-time employees. The company went IPO on 2018-06-21. The firm is focused on developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The firm has three commercial products: Gvoke, Keveyis and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative. Its product candidate also includes Ogluo (EU), Self-Administered Glucagon for prevention, Levothyroxine and XP-9164. The firm uses its non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize its products.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet